n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cancer of Mouth in 9 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arecoline was found to elevate HSP27 expression in a dose- and time-dependent manner (P < 0." | 1.38 | Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas. ( Chang, YC; Ho, YC; Lee, SS; Tsai, CH; Yu, CC, 2012) |
| "Oral squamous cell carcinoma (OSCC) is the sixth most common cancer and frequently metastasizes to the cervical lymph nodes, leading to poor survival of patients with OSCC." | 1.38 | Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. ( Hata, K; Morita, Y; Nakanishi, M; Nishisho, T; Yoneda, T; Yura, Y, 2012) |
| "Worldwide oral squamous cell carcinoma (OSCC) represents about 5." | 1.33 | Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. ( Hart, IR; Marshall, JF; McCulloch, D; Nystrom, ML; Speight, PM; Thomas, GJ; Violette, SM; Weinreb, PH, 2006) |
| "In the present study, human oral squamous cell carcinoma (OSCC) cell lines NA and HSC-4 were used to evaluate the effects of NS-398, a selective inhibitor of COX-2, and COX-2 antisense oligonucleotide (COX-2 AS) on the invasion activity of OSCC cells." | 1.32 | Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. ( Hatori, M; Ito, D; Ito, H; Kinugasa, Y; Kurihara, Y; Nagumo, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, R | 1 |
| Imanishi, Y | 1 |
| Shibata, K | 1 |
| Sakai, N | 1 |
| Sakamoto, K | 1 |
| Shigetomi, S | 1 |
| Habu, N | 1 |
| Otsuka, K | 1 |
| Sato, Y | 1 |
| Watanabe, Y | 1 |
| Ozawa, H | 1 |
| Tomita, T | 1 |
| Kameyama, K | 1 |
| Fujii, M | 1 |
| Ogawa, K | 1 |
| Du, Y | 1 |
| Zhang, S | 1 |
| Wang, Z | 1 |
| Zhou, W | 1 |
| Luan, M | 1 |
| Yang, X | 1 |
| Chen, N | 1 |
| Muraki, C | 1 |
| Ohga, N | 1 |
| Hida, Y | 1 |
| Nishihara, H | 1 |
| Kato, Y | 1 |
| Tsuchiya, K | 1 |
| Matsuda, K | 1 |
| Totsuka, Y | 1 |
| Shindoh, M | 1 |
| Hida, K | 1 |
| Lee, SS | 1 |
| Tsai, CH | 1 |
| Ho, YC | 1 |
| Yu, CC | 1 |
| Chang, YC | 1 |
| Morita, Y | 1 |
| Hata, K | 1 |
| Nakanishi, M | 1 |
| Nishisho, T | 1 |
| Yura, Y | 1 |
| Yoneda, T | 1 |
| Sun, XJ | 1 |
| Xie, H | 1 |
| Wang, XK | 1 |
| Zhang, H | 1 |
| Song, CX | 1 |
| Zhang, YJ | 1 |
| Minter, HA | 1 |
| Eveson, JW | 1 |
| Huntley, S | 1 |
| Elder, DJ | 1 |
| Hague, A | 1 |
| Kinugasa, Y | 1 |
| Hatori, M | 1 |
| Ito, H | 1 |
| Kurihara, Y | 1 |
| Ito, D | 1 |
| Nagumo, M | 1 |
| Nystrom, ML | 1 |
| McCulloch, D | 1 |
| Weinreb, PH | 1 |
| Violette, SM | 1 |
| Speight, PM | 1 |
| Marshall, JF | 1 |
| Hart, IR | 1 |
| Thomas, GJ | 1 |
9 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cancer of Mouth
| Article | Year |
|---|---|
Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxy | 2014 |
Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Cell Proliferation; Cyclooxygenas | 2008 |
Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
Topics: Animals; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cy | 2012 |
Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas.
Topics: Acetylcysteine; Areca; Arecoline; Carcinoma, Squamous Cell; Case-Control Studies; Catechin; Cyclooxy | 2012 |
Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2012 |
[The influence of COX-2 depressant in angiogenesis of oral squamous cell carcinoma].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Down-Regulation; Humans; Mo | 2012 |
The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycl | 2003 |
Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloox | 2004 |
Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Neoplasm; Carcinoma, Squamous Cell; Cell | 2006 |